Crossmark

Mechanisms of treatment effects using allogeneic, umbilical cord-derived mesenchymal stromal stem cells (MSCs) in knee osteoarthritis: a pharmacological clinical study protocol

Crossref DOI link: https://doi.org/10.1186/s13063-024-08360-x

Published Online: 2024-08-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Švajger, Urban http://orcid.org/0000-0002-1908-4254
Kolar, Matic

Kobold, Andrej

Drobnič, Matej
Funding

Funding for this research was provided by:

Javna Agencija za Raziskovalno Dejavnost RS (P3-0371)
License Information

Text and Data Mining valid from 2024-08-13

Version of Record valid from 2024-08-13
More Information

Article History

Received: 15 March 2024

Accepted: 30 July 2024

First Online: 13 August 2024

Declarations

:

: The study has been approved by the National Medical Ethics Committee of Slovenia on 27 July, 2022. The approval number is 0120–273/2022/3.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below